Aqueous pharmaceutical composition comprising a p2y12 receptor antagonist

TW202633635APending Publication Date: 2026-08-16VIATRIS ASIA PACIFIC PTE LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114141142
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2020-07-15
Filing Date
2021-07-14
Publication Date
2026-08-16

Smart Images

  • Figure TWG2TA001072832_001
    Figure TWG2TA001072832_001
  • Figure TWG2TA001072832_002
    Figure TWG2TA001072832_002
  • Figure TWG2TA001072832_003
    Figure TWG2TA001072832_003
Patent Text Reader

Abstract

This invention relates to an aqueous pharmaceutical composition comprising the P2Y12 receptor antagonist 4-((R)-2-{[6-((S)-3-methoxy-pyrrolidin-1-yl)-2-phenyl-pyrimidin-4-carbonyl]amino}-3-phosphino-propionic)-piperazine-1-carboxylate butyl ester and a pharmaceutically acceptable buffer, and its use as a pharmaceutical preparation by non-enteral administration. The present invention relates to an aqueous pharmaceutical composition comprising the P2Y12 receptor antagonist 4-((R)-2-{[6-((S)-3-methoxy-pyrrolidin-1-yl)-2-phenyl-pyrimidine-4-carbonyl]-amino}-3-phosphono-propionyl)-piperazine-1-carboxylic acid butyl ester and a pharmaceutically acceptable buffer and its use as a medicine by parenteral administration.
Need to check novelty before this filing date? Find Prior Art